84 related articles for article (PubMed ID: 15279813)
1. Radiation-induced tissue damage and response.
McBride WH; Schaue D
J Pathol; 2020 Apr; 250(5):647-655. PubMed ID: 31990369
[TBL] [Abstract][Full Text] [Related]
2. Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy.
Cellini F; Morganti AG; Genovesi D; Silvestris N; Valentini V
Molecules; 2014 Apr; 19(4):5379-401. PubMed ID: 24879584
[TBL] [Abstract][Full Text] [Related]
3. The clinical manifestations and molecular pathogenesis of radiation fibrosis.
Fijardo M; Kwan JYY; Bissey PA; Citrin DE; Yip KW; Liu FF
EBioMedicine; 2024 May; 103():105089. PubMed ID: 38579363
[TBL] [Abstract][Full Text] [Related]
4. Meeting report on ICRR2019, the 16th International Congress on Radiation Research.
Williams KJ; Hammond EM; West C; Anderson RM; Badie C; Jeggo PA
Int J Radiat Biol; 2020 Feb; 96(2):167-171. PubMed ID: 31702416
[TBL] [Abstract][Full Text] [Related]
5. Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.
van Barele M; Akdeniz D; Heemskerk-Gerritsen BAM; ; Andrieu N; Noguès C; ; van Asperen CJ; Wevers M; Ausems MGEM; de Bock GH; Dommering CJ; Gómez-García EB; van Leeuwen FE; Mooij TM; ; Easton DF; Antoniou AC; Evans DG; Izatt L; Tischkowitz M; Frost D; Brewer C; Olah E; Simard J; Singer CF; Thomassen M; Kast K; Rhiem K; Engel C; de la Hoya M; Foretová L; Jakubowska A; Jager A; Sattler MGA; Schmidt MK; Hooning MJ
J Natl Cancer Inst; 2023 Nov; 115(11):1318-1328. PubMed ID: 37369040
[TBL] [Abstract][Full Text] [Related]
6. miRNA‑30a‑3p inhibits metastasis and enhances radiosensitivity in esophageal carcinoma by targeting insulin‑like growth factor 1 receptor.
Fan Y; Bian X; Qian P; Wen J; Yan P; Luo Y; Wu J; Zhang Q
Mol Med Rep; 2019 Jul; 20(1):81-94. PubMed ID: 31115568
[TBL] [Abstract][Full Text] [Related]
7. Modulators of Redox Metabolism in Head and Neck Cancer.
Chen X; Mims J; Huang X; Singh N; Motea E; Planchon SM; Beg M; Tsang AW; Porosnicu M; Kemp ML; Boothman DA; Furdui CM
Antioxid Redox Signal; 2018 Dec; 29(16):1660-1690. PubMed ID: 29113454
[TBL] [Abstract][Full Text] [Related]
8. Role of Nrf2 signaling pathway in the radiation tolerance of patients with head and neck squamous cell carcinoma: an in vivo and in vitro study.
Wang T; Hu P; Li B; Zhang JP; Cheng YF; Liang YM
Onco Targets Ther; 2017; 10():1809-1819. PubMed ID: 28367064
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.
Drooger J; Akdeniz D; Pignol JP; Koppert LB; McCool D; Seynaeve CM; Hooning MJ; Jager A
Breast Cancer Res Treat; 2015 Nov; 154(1):171-80. PubMed ID: 26467044
[TBL] [Abstract][Full Text] [Related]
10. Ionizing radiation: mechanisms and therapeutics.
Furdui CM
Antioxid Redox Signal; 2014 Jul; 21(2):218-20. PubMed ID: 24702164
[TBL] [Abstract][Full Text] [Related]
11. γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers.
Fu S; Yang Y; Das TK; Yen Y; Zhou BS; Zhou MM; Ohlmeyer M; Ko EC; Cagan R; Rosenstein BS; Chen SH; Kao J
PLoS One; 2012; 7(6):e38465. PubMed ID: 22768044
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of lung cancer prognosis: quantity and quality of life.
Yang P
Methods Mol Biol; 2009; 471():469-86. PubMed ID: 19109795
[TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.
Molina JR; Yang P; Cassivi SD; Schild SE; Adjei AA
Mayo Clin Proc; 2008 May; 83(5):584-94. PubMed ID: 18452692
[TBL] [Abstract][Full Text] [Related]
14. Relevance and irrelevance of DNA damage response to radiotherapy.
Connell PP; Kron SJ; Weichselbaum RR
DNA Repair (Amst); 2004; 3(8-9):1245-51. PubMed ID: 15279813
[TBL] [Abstract][Full Text] [Related]
15. Exposure to low dose ionising radiation: molecular and clinical consequences.
Martin LM; Marples B; Lynch TH; Hollywood D; Marignol L
Cancer Lett; 2013 Sep; 338(2):209-18. PubMed ID: 23693079
[TBL] [Abstract][Full Text] [Related]
16. Molecular aspects of individual radiosensitivity.
Benotmane MA
J Biol Regul Homeost Agents; 2004; 18(3-4):357-62. PubMed ID: 15786705
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients.
Chistiakov DA; Voronova NV; Chistiakov PA
Acta Oncol; 2008; 47(5):809-24. PubMed ID: 18568480
[TBL] [Abstract][Full Text] [Related]
18. Locations of mouse DNA damage response and repair loci, and cancer risk modifiers.
Bulman RA; Dragani TA; Bouffler SD; Cox R
DNA Repair (Amst); 2006 Feb; 5(2):274-7. PubMed ID: 16290248
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaks.
Nübel T; Damrot J; Roos WP; Kaina B; Fritz G
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):933-9. PubMed ID: 16467108
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
